UniProtKB/Swiss-Prot P02768: Variant p.Glu121Gly

• Variant information
• Sequence information
• Literature citations
• All

Variant information

Variant position: 121 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: LB/B The variants are classified into three categories: LP/P, LB/B and US.

• LP/P: likely pathogenic or pathogenic.
• LB/B: likely benign or benign.
• US: uncertain significance

Residue change: From Glutamate (E) to Glycine (G) at position 121 (E121G, p.Glu121Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Change from medium size and acidic (E) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

• Lowest score: -4 (low probability of substitution).
• Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism: A variant structure of albumin could lead to increased binding of zinc resulting in an asymptomatic augmentation of zinc concentration in the blood. The sequence shown is that of variant albumin A. Additional information on the polymorphism described.

Sequence information

Variant position: 121 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 609 The length of the canonical sequence.
Location on the sequence: VATLRETYGEMADCCAKQEP E RNECFLQHKDDNPNLPRLVR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

• Type: the type of sequence feature.
• Positions: endpoints of the sequence feature.
• Description: contains additional information about the feature.

Type	Positions	Description
Chain	25 – 609	Albumin
Domain	19 – 210	Albumin 1
Site	117 – 117	Not glycated
Site	130 – 130	Not glycated
Modified residue	107 – 107	Phosphothreonine; by FAM20C
Disulfide bond	114 – 125
Alternative sequence	43 – 234	Missing. In isoform 2.
Helix	121 – 128

Literature citations

Nucleotide sequence and the encoded amino acids of human serum albumin mRNA.
Dugaiczyk A.; Law S.W.; Dennison O.E.;
Proc. Natl. Acad. Sci. U.S.A. 79:71-75(1982)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT GLY-121;